Alligator Bioscience: Interview with CEO Søren Bregenholt about OPTIMIZE-1
Research Interview
2024-01-29
14:05
Redeye has interviewed Søren Bregenholt, CEO of Alligator Bioscience, about the positive topline results from OPTIMIZE-1, the study of mitazalimab in first-line metastatic pancreatic cancer.
RR
Richard Ramanius
Disclosures and disclaimers